acute Archives - AudioMedica.com

Tagged: acute

0
- in Cardiovascular
- — 15 Apr, 2008
Remove Thrombus Before Primary Angioplasty!
Felix Zijlstra
Felix Zijlstra, University Medical Center Groningen, The Netherlands
Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits, according to data from the 1000-patient TAPAS study presented at the ACC meeting. Senior investigator Felix
…
Read more
0
- in Cardiovascular
- — 13 Apr, 2008
Heart Failure Drug Prevents Renal Damage?
Barry Massie
Barry Massie, San Francisco VA Medical Center
COMMENT: Aaron Kugelmass, Henry Ford Hospital, Detroit
The adenosine A1-receptor antagonist rolofylline appears to prevent renal impairment and improve acute heart failure symptoms. Barry Massie and Aaron Kugelmass discussed
…
Read more
Interleukin-2 For Acute Myeloid Leukemia In First Remission?" /> 0
- in Oncology
- — 10 Dec, 2007
Live Report from ASH:
Interleukin-2 For Acute Myeloid Leukemia In First Remission?

Jonathan Kolitz
JONATHAN KOLITZ, Monter Cancer Center, Lake Success, NY
GEORGE CANELLOS, Dana-Farber Cancer Institute
For patients with acute myeloid leukemia in first remission, new data suggests that there may be a benefit from interleukin-2. Derek Thorne got the interim
…
Read more
0
- in Cardiovascular
- — 6 Nov, 2007
Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study

Uwe Zeymer
REFERENCE: Late Breaking Clinical Trials Session I, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
UWE ZEYMER, Herzzentrum Ludwigshafen, Germany
The glycoprotein 2B 3A antagonist eptifibatide has performed as well as standard abciximab therapy in patients
…
Read more
0
- in Cardiovascular
- — 5 Nov, 2007
TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?

Gordon Tomaselli

Daniel Jones
REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
GORDON TOMASELLI, Johns Hopkins University, Baltimore
COMMENT: DANIEL JONES, President, American Heart Association, University of Mississippi, Jackson
A potential new
…
Read more
0
- in Cardiovascular
- — 5 Sep, 2007
Heart Attacks Drop After Smoking Ban in Ireland

Edmond Cronin
REFERENCE: Abstract 3506, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
EDMOND CRONIN, Cork University Hospital
Study data that support banning smoking in public places were unveiled at the ESC congress by a team from Ireland.
…
Read more

in Cardiovascular
— 18 Nov, 2006

Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006

Thorsten Dill

Simon Hoerstrup

Harvey White

REPAIR-AMI Study: Bone Marrow Cells Improve Ejection Fraction, Reduce Remodeling

REFERENCE: Abstract: 3770
THORSTEN DILL, Kerckhoff-Klinik, Bad Nauheim
Progenitor cells from bone marrow, infused directly into coronary arteries of patients with ST-elevation myocardial infarction,

…

in Cardiovascular
— 5 Sep, 2006

Audio Journal of Cardiovascular Medicine: September 5th 2006

Shamir Mehta

Keith Fox

Petr Widimsky

Gerrit Veen

OASIS 5 & 6: Fondaparinux Anticoagulation: Benefit on Mortality, Events and Bleeding in Acute Coronary Syndromes and ST-Elevation Myocardial Infarction

REFERENCE: Abstract 1745
Shamir Mehta, McMaster University, Hamilton, Canada
Results in over

…

0
- in ACC 2006
- — 29 Mar, 2006
Do Blood Transfusions Increase Mortality Risk in Patients with Acute Myocardial Infarction?
Vivek Rajagopal, The Cleveland Clinic Foundation, OH
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 973-234
Patients admitted with ST-elevation acute myocardial infarction should not routinely be given blood transfusions according to the findings of
…
Read more
0
- in ACC 2006
- — 27 Mar, 2006
Acute Coronary Syndromes: Big Mortality Reduction from Early Aggressive Statins
Anthony Bavry, The Cleveland ClinIc, OH
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 821-5
All cause mortality can be reduced by 25 per cent if you give your acute coronary syndrome patients early aggressive
…
Read more
0
- in ACC 2006
- — 13 Mar, 2006
Single Agent Bivalirudin Better for Acute Coronary Syndromes
Gregg Stone, Columbia University Medical Center, New York
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
A superiority for the anti-clotting drug bivalirudin for treating patients with acute coronary syndromes was detected when this was used as
…
Read more
0
- in ACC 2006
- — 13 Mar, 2006
Bivalirudin in ACS: The Acuity Study Findings
Michael Lincoff, Cleveland Clilnic, Cleveland Ohio
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The full picture of how bivalirudin is emerging as a treatment without also using glycoprotein IIb/IIIa inhibition in cases of acute coronary syndrome
…
Read more

Tagged: acute

REPAIR-AMI Study: Bone Marrow Cells Improve Ejection Fraction, Reduce Remodeling

OASIS 5 & 6: Fondaparinux Anticoagulation: Benefit on Mortality, Events and Bleeding in Acute Coronary Syndromes and ST-Elevation Myocardial Infarction

Sign up for AudioMedica.com news